A 20-Week Multicenter, Randomized, Double-Blind (DB), Placebo-Controlled, Phase 3 Trial (EPX 100-003) of EPX-100 (Clemizole Hydrochloride) as Adjunctive Therapy in patients with Lennox-Gastaut Syndrome (LGS) (P8-9.007).

Neurology

Amit Ray, George Nomikos, Grant Runyan, Juby Philip, David Albers, Scott Baraban, Kumar Budur. A 20-Week Multicenter, Randomized, Double-Blind (DB), Placebo-Controlled, Phase 3 Trial (EPX 100-003) of EPX-100 (Clemizole Hydrochloride) as Adjunctive Therapy in patients with Lennox-Gastaut Syndrome (LGS) (P8-9.007). Neurology. 2025 Apr 8; 104(7_Supplement_1).

2025

https://researcherprofiles.org/profile/607348168

Amit Ray, George Nomikos, Grant Runyan, Juby Philip, David Albers, Scott Baraban, Kumar Budur

Search form

You are here

A 20-Week Multicenter, Randomized, Double-Blind (DB), Placebo-Controlled, Phase 3 Trial (EPX 100-003) of EPX-100 (Clemizole Hydrochloride) as Adjunctive Therapy in patients with Lennox-Gastaut Syndrome (LGS) (P8-9.007).